Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gene Engineering Institute (GEI) is a Japanese biotechnology company specializing in advanced genetic engineering services and the development of high-efficiency gene expression systems. The company provides comprehensive contract research services, including custom vector construction, recombinant protein production, and the generation of stable cell lines for pharmaceutical research. GEI is particularly recognized for its proprietary technologies in optimizing gene expression for complex proteins and its contributions to the development of gene and cell therapy components. By leveraging its expertise in molecular biology, the institute supports drug discovery and diagnostic development for global pharmaceutical and academic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gene Engineering Institute.